Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Science
Storm Newton

People with blood cancer to benefit from innovative new treatment on the NHS

Hundreds of people in England with aggressive blood cancer are set to benefit from an innovative new treatment that reprogrammes a patient’s own immune cells to fight the disease after it was recommended for NHS use.

Lisocabtagene maraleucel – also called liso-cel or Breyanzi and made by Bristol Myers Squibb – has been given the green light by the National Institute for Health and Care Excellence.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.